![Alexandra Bause](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Alexandra Bause
Oprichter bij Apollo Ventures Holding GmbH
Profiel
Alexandra Bause is the founder of Apollo Ventures Holding GmbH.
She is currently working as a Director at Cleara Biotech BV.
Dr. Bause holds a doctorate degree from Harvard University.
Actieve functies van Alexandra Bause
Bedrijven | Functie | Begin |
---|---|---|
Apollo Ventures Holding GmbH
![]() Apollo Ventures Holding GmbH Investment ManagersFinance Apollo Ventures Holding GmbH (Apollo Health Ventures) is an Independent Venture Capital firm founded in 2016 by Nils Regge and Alexandra Bause. The firm is headquartered in Hamburg. | Oprichter | - |
Cleara Biotech BV
![]() Cleara Biotech BV Pharmaceuticals: MajorHealth Technology Cleara Biotech BV operates as a biopharmaceutical company. It specializes in identification and specific elimination of subtypes of senescent cells with targeting age related diseases and counteracting therapy resistance in late stage cancer. The company was founded by Peter de Keizer, Marco Demaria, Tobias Madl and is headquartered in Utrecht, the Netherlands. | Directeur/Bestuurslid | - |
Opleiding van Alexandra Bause
Harvard University | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
Apollo Ventures Holding GmbH
![]() Apollo Ventures Holding GmbH Investment ManagersFinance Apollo Ventures Holding GmbH (Apollo Health Ventures) is an Independent Venture Capital firm founded in 2016 by Nils Regge and Alexandra Bause. The firm is headquartered in Hamburg. | Finance |
Cleara Biotech BV
![]() Cleara Biotech BV Pharmaceuticals: MajorHealth Technology Cleara Biotech BV operates as a biopharmaceutical company. It specializes in identification and specific elimination of subtypes of senescent cells with targeting age related diseases and counteracting therapy resistance in late stage cancer. The company was founded by Peter de Keizer, Marco Demaria, Tobias Madl and is headquartered in Utrecht, the Netherlands. | Health Technology |